Works matching IS 03057453 AND DT 2003 AND VI 52 AND IP 3

Results: 46

Effect of protease inhibitor-containing regimens on lymphocyte multidrug resistance transporter expression.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 354, doi. 10.1093/jac/dkg381

By:

J. Ford;
E.R. Meaden;
P.G. Hoggard;
M. Dalton;
P. Newton;
I. Williams;
S.H. Khoo;
D.J. Back

Publication type:

Article

Comparative activity of telithromycin against typical community-acquired respiratory pathogens.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 371, doi. 10.1093/jac/dkg359

By:

A. Buxbaum;
S. Forsthuber;
W. Graninger;
A. Georgopoulos

Publication type:

Article

Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 365, doi. 10.1093/jac/dkg384

By:

E. Martín-Mazuelos;
J. Pemán;
A. Valverde;
M. Chaves;
M.C. Serrano;
E. Cantón

Publication type:

Article

Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 359, doi. 10.1093/jac/dkg357

By:

V. Hommer;
J. Eichholz;
F. Petry

Publication type:

Article

Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 375, doi. 10.1093/jac/dkg372

By:

A. Arzese;
B. Skerlavaj;
L. Tomasinsig;
R. Gennaro;
M. Zanetti

Publication type:

Article

Intrapulmonary penetration of linezolid.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 536, doi. 10.1093/jac/dkg435

By:

D. Honeybourne;
C. Tobin;
G. Jevons;
J. Andrews;
R. Wise

Publication type:

Article

Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 535, doi. 10.1093/jac/dkg436

By:

V. Hommer;
J. Eichholz;
F. Petry

Publication type:

Article

Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 533, doi. 10.1093/jac/dkg369

By:

J. Cepeda;
S. Hayman;
T. Whitehouse;
C.C. Kibbler;
D. Livermore;
M. Singer;
A.P.R. Wilson

Publication type:

Article

Absence of vancomycin-resistant enterococci (VRE) in companion dogs in the conurbation of Parkstad Limburg, The Netherlands.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 532, doi. 10.1093/jac/dkg374

By:

J.H.T. Wagenvoort;
D.M.T. Burgers;
T.H.C. Wagenvoort;
E. Burgers

Publication type:

Article

Occurrence and spread of SHV extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in Curaçao.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 530, doi. 10.1093/jac/dkg382

By:

M. van Westreenen;
A. Paauw;
A.C. Fluit;
S. Brisse;
W. van Dijk;
J. Verhoef

Publication type:

Article

Detection of CTX-M-15 extended-spectrum β-lactamase in the United Kingdom.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 528, doi. 10.1093/jac/dkg353

By:

S. Mushtaq;
N. Woodford;
N. Potz;
D.M. Livermore

Publication type:

Article

Bactericidal activity of levofloxacin against Mycoplasma pneumoniae.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 527, doi. 10.1093/jac/dkg365

By:

L.B. Duffy;
D.M. Crabb;
X. Bing;
K.B. Waites

Publication type:

Article

High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 345, doi. 10.1093/jac/dkg348

By:

F. Walsh;
J. Willcock;
S. Amyes

Publication type:

Article

Determination of in vitro susceptibility to ABT-492 by BSAC standardized methodology.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 526, doi. 10.1093/jac/dkg328

By:

J.M. Andrews;
J.P. Ashby;
G. Jevons;
R. Wise

Publication type:

Article

Reply.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 525, doi. 10.1093/jac/dkg350

By:

J. Verhaegen;
W. Peetermans;
L. Verbist

Publication type:

Article

Significance of macrolide resistance in Streptococcus pneumoniae.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 524, doi. 10.1093/jac/dkg349

By:

E.L. Nuermberger;
W.R. Bishai

Publication type:

Article

Mastic gum has no effect on Helicobacter pylori load in vivo.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 522, doi. 10.1093/jac/dkg366

By:

J.R. Bebb;
N. Bailey-Flitter;
D. Ala'Aldeen;
J.C. Atherton

Publication type:

Article

Comparison of the pharmacodynamics of meropenem in healthy volunteers following administration by intermittent infusion or bolus injection.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 518, doi. 10.1093/jac/dkg378

By:

S. Jaruratanasirikul;
S. Sriwiriyajan

Publication type:

Article

Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 514, doi. 10.1093/jac/dkg360

By:

J. Gavaldà;
P.L. Onrubia;
M.T.M. Gómez;
X. Gomis;
J.L. Ramírez;
O. Len;
D. Rodríguez;
M. Crespo;
I. Ruíz;
A. Pahissa

Publication type:

Article

Pharmacodynamics of linezolid in a clinical isolate of Streptococcus pneumoniae genetically modified to express lux genes.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 511, doi. 10.1093/jac/dkg334

By:

H.M. Alloush;
V. Salisbury;
R.J. Lewis;
A.P. MacGowan

Publication type:

Article

Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 507, doi. 10.1093/jac/dkg379

By:

L.P. Randall;
A.M. Ridley;
S.W. Cooles;
M. Sharma;
A.R. Sayers;
L. Pumbwe;
D.G. Newell;
L.J.V. Piddock;
M.J. Woodward

Publication type:

Article

Comparative antimicrobial activity of levofloxacin and ciprofloxacin against Streptococcus pneumoniae.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 503, doi. 10.1093/jac/dkg380

By:

M.W. Garrison

Publication type:

Article

Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 500, doi. 10.1093/jac/dkg373

By:

L.J.V. Piddock;
M.M. Johnson;
M.A. Webber

Publication type:

Article

Properties and potential of ertapenem.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 331, doi. 10.1093/jac/dkg375

By:

D.M. Livermore;
A.M. Sefton;
G.M. Scott

Publication type:

Article

Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 324, doi. 10.1093/jac/dkg354

By:

F. Baldanti;
G. Gerna

Publication type:

Article

Diversity of TEM-52 extended-spectrum β-lactamase-producing non-typhoidal Salmonella isolates in Korea.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 493, doi. 10.1093/jac/dkg385

By:

K. Lee;
D. Yong;
J.H. Yum;
H.H. Kim;
Y. Chong

Publication type:

Article

Phenotypic and genotypic characterization of antimicrobial resistance in German Escherichia coli isolates from cattle, swine and poultry.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 489, doi. 10.1093/jac/dkg362

By:

B. Guerra;
E. Junker;
A. Schroeter;
B. Malorny;
S. Lehmann;
R. Helmuth

Publication type:

Article

Clonal diversity among erythromycin-resistant β-haemolytic Streptococcus isolates in La Rioja, Spain.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 485, doi. 10.1093/jac/dkg347

By:

A. Portillo;
M.J. Gastañares;
F. Ruiz-Larrea;
C. Torres

Publication type:

Article

Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 481, doi. 10.1093/jac/dkg368

By:

M.L. Peterson;
J.C. Rotschafer;
L.J.V. Piddock

Publication type:

Article

In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 497, doi. 10.1093/jac/dkg371

By:

N. Miyashita;
H. Fukano;
K. Yoshida;
Y. Niki;
T. Matsushima

Publication type:

Article

A multicentre comparison of a novel surrogate marker for determining the specific potency of anti-tuberculosis drugs.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 473, doi. 10.1093/jac/dkg345

By:

R.D. Gosling;
L. Heifets;
S.H. Gillespie

Publication type:

Article

Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 469

By:

C. Spiegel;
M.W. Dunne;
D. Boettger;
T. Latiolais;
A. Shemer;
B. Lewis;
B. Pistorius;
G. Bottenfield;
W.H. Moore;
A. Garrett;
T.D. Stewart;
J. Aoki

Publication type:

Article

Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 464

By:

R. López-Vélez;
F. Laguna;
J. Alvar;
S. Videla;
M.E. Jiménez-Mejías;
G. Sirera;
J. Torre-Cisneros;
E. Ribera;
D. Prados;
B. Clotet;
M. Sust

Publication type:

Article

Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 457, doi. 10.1093/jac/dkg342

By:

J.A. Paladino;
J.L. Sunderlin;
A. Forrest;
J.J. Schentag

Publication type:

Article

Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 477, doi. 10.1093/jac/dkg344

By:

A. Ribera;
I. Roca;
J. Ruiz;
I. Gibert;
J. Vila

Publication type:

Article

Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 450, doi. 10.1093/jac/dkg355

By:

M.H. Gotfried;
L.H. Danziger;
K.A. Rodvold

Publication type:

Article

Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 441, doi. 10.1093/jac/dkg338

By:

A.G. Schijman;
J. Altcheh;
J.M. Burgos;
M. Biancardi;
M. Bisio;
M.J. Levin;
H. Freilij

Publication type:

Article

Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 435, doi. 10.1093/jac/dkg370

By:

P.G. Ambrose;
S.M. Bhavnani;
B.B. Cirincione;
M. Piedmonte;
T.H. Grasela

Publication type:

Article

Comparison of microbial adherence to antiseptic and antibiotic central venous catheters using a novel agar subcutaneous infection model.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 389, doi. 10.1093/jac/dkg361

By:

T.A. Gaonkar;
S.M. Modak

Publication type:

Article

Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 419, doi. 10.1093/jac/dkg351

By:

M.S. Espuelas;
P. Legrand;
M.A. Campanero;
M. Appel;
M. Chéron;
C. Gamazo;
G. Barratt;
J.M. Irache

Publication type:

Article

In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 412, doi. 10.1093/jac/dkg383

By:

N. Lincopan;
E.M. Mamizuka;
A.M. Carmona-Ribeiro

Publication type:

Article

Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 405, doi. 10.1093/jac/dkg337

By:

P.K. Dandekar;
P.R. Tessier;
P. Williams;
C.H. Nightingale;
D.P. Nicolau

Publication type:

Article

Characterization of pentamidine excretion in the isolated perfused rat kidney.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 397, doi. 10.1093/jac/dkg341

By:

N.R. Poola;
M. Kalis;
F.M. Plakogiannis;
D.R. Taft

Publication type:

Article

Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 428, doi. 10.1093/jac/dkg367

By:

M.J. Becker;
S. de Marie;
M.H.A.M. Fens;
H.A. Verbrugh;
I.A.J.M. Bakker-Woudenberg

Publication type:

Article

Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 382, doi. 10.1093/jac/dkg352

By:

G.G. Zhanel;
N.M. Laing;
K.A. Nichol;
L.P. Palatnick;
A. Noreddin;
T. Hisanaga;
J.L. Johnson;
D.J. Hoban

Publication type:

Article

Differentiation of genotypic resistance profiles for amprenavir and lopinavir, a valuable aid for choice of therapy in protease inhibitor-experienced HIV-1-infected subjects.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 3, p. 319, doi. 10.1093/jac/dkg392

By:

D. Paulsen;
R. Elston;
W. Snowden;
M. Tisdale;
L. Ross

Publication type:

Article